Protalix BioTherapeutics Inc (PLX) Stock Price, Quote, News & History

PLXAMEX
$1.98
-0.02-1.00%
At close: May 15, 5:00 PM EST
Earnings: Q1 2026 Earnings were released on Wed May 13th, before the market open
Conference Call: The most recent conference call started at 8:00 AM, 5 days ago
Click to view the webcast
60%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
15.09M
Investing Cash Flow (TTM)
2.17M
Financing Cash Flow (TTM)
4.40M
Free Cash Flow (TTM)
13.00M
Capital Expenditure (TTM)
-2.09M
Net Change in Cash (TTM)
21.66M

Analyst Trends and Forecast

1
Nov 25
1
Mar
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$116.93M
PE Ratio (TTM)
10.42
PE Ratio (FWD)
9.21
PEG Ratio (TTM)
-
PS Ratio (TTM)
2.08
PB Ratio (TTM)
2.37
Earnings Yield % (TTM)
9.60%
Earnings Yield % (FWD)
10.86%
EV / EBITDA (TTM)
5.28
Price / EBITDA (TTM)
7.16
Price / Free Cash Flow (TTM)
12.21
Book Value / Share
$0.83

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$41.00M
Debt to Equity
0.13
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$1.98
Volume / Avg.
41.00 / 993.40K
Day Range
- - -
52 Wk Range
1.32 - 3.19
Market Cap
$159.53M
P/E Ratio
10.42
Dividend Yield
-
Exchange
AMEX
RSI
46
Short Interest
6.53%
Days to Cover
9.74

About

Sector
Health Care
Industry
Biotechnology
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-ba...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Protalix BioTherapeutics (PLX) stock?

A

You can purchase shares of Protalix BioTherapeutics (AMEX:PLX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Protalix BioTherapeutics (PLX) competitors?

A

There are no as such competitors for Protalix BioTherapeutics.

Q

What is the forecast, or price target, for Protalix BioTherapeutics (PLX) stock?

A

Protalix BioTherapeutics has a consensus price target of $12.00.

Q

What is the current price for Protalix BioTherapeutics (PLX)?

A

The stock price for Protalix BioTherapeutics (AMEX: PLX) is $ last updated .

Q

Does Protalix BioTherapeutics (PLX) pay a dividend?

A

There are no upcoming dividends for Protalix BioTherapeutics.

Q

When is Protalix BioTherapeutics (AMEX:PLX) reporting earnings?

A

Protalix BioTherapeutics does not have any upcoming earnings scheduled.

Q

Is Protalix BioTherapeutics (PLX) going to split?

A

There is no upcoming split for Protalix BioTherapeutics.

Q

What sector and industry does Protalix BioTherapeutics (PLX) operate in?

A

Protalix BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.